Revolution Medicines Inc

NAS:RVMDHealthcareNASDAQ:NBINASDAQ:NQUSLG

$182.15+2.35%At closeAt close · Tue 20 Oct · ≈ AED 668.95 · Market cap $39.04B · Next earnings Wed 4 Nov · Extended $182.14 −0.01%

Collaboration Revenue Member100%+20%

Share of FY2022 revenue · growth vs FY2021

No breakdown of this kind is reported.

Segment / region	Type	Fiscal year	Currency	Revenue (millions)	Share of revenue
Collaboration Revenue Member	Product	2022	USD	35.4	100.0%
Collaboration Revenue Member	Product	2021	USD	29.4	100.0%
Collaboration Revenue Related Party	Product	2020	USD	43.0	100.0%

Revenue by product and region · reported currencyUpdated 31 Dec 2022 ·

ⓘ

Product and geographic breakdowns describe the same revenue from different perspectives and should not be added together.